141 related articles for article (PubMed ID: 28982134)
1. A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry.
De Carolis E; Paoletti S; Nagel D; Vella A; Mello E; Palucci I; De Angelis G; D'Inzeo T; Sanguinetti M; Posteraro B; Spanu T
PLoS One; 2017; 12(10):e0185935. PubMed ID: 28982134
[TBL] [Abstract][Full Text] [Related]
2. Ease-of-use protocol for the rapid detection of third-generation cephalosporin resistance in Enterobacteriaceae isolated from blood cultures using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.
Foschi C; Compri M; Smirnova V; Denicolò A; Nardini P; Tamburini MV; Lombardo D; Landini MP; Ambretti S
J Hosp Infect; 2016 Jun; 93(2):206-10. PubMed ID: 27105753
[TBL] [Abstract][Full Text] [Related]
3. Rapid detection of antibiotic resistance in positive blood cultures by MALDI-TOF MS and an automated and optimized MBT-ASTRA protocol for
Axelsson C; Rehnstam-Holm AS; Nilson B
Infect Dis (Lond); 2020 Jan; 52(1):45-53. PubMed ID: 31661349
[No Abstract] [Full Text] [Related]
4. Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures.
Torres I; Albert E; Giménez E; Olea B; Valdivia A; Pascual T; Huntley D; Sánchez D; Costa RM; Pinto C; Oltra R; Colomina J; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1925-1932. PubMed ID: 33876385
[TBL] [Abstract][Full Text] [Related]
5. Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS.
Sauget M; Bertrand X; Hocquet D
PLoS One; 2018; 13(10):e0205603. PubMed ID: 30308072
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
Sakarikou C; Ciotti M; Dolfa C; Angeletti S; Favalli C
BMC Microbiol; 2017 Mar; 17(1):54. PubMed ID: 28274205
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay.
Idelevich EA; Sparbier K; Kostrzewa M; Becker K
Clin Microbiol Infect; 2018 Jul; 24(7):738-743. PubMed ID: 29079147
[TBL] [Abstract][Full Text] [Related]
8. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
9. Rapid detection of colistin-resistant Klebsiella pneumoniae using MALDI-TOF MS peak-based assay.
Giordano C; Barnini S
J Microbiol Methods; 2018 Dec; 155():27-33. PubMed ID: 30439463
[TBL] [Abstract][Full Text] [Related]
10. Summation of peaks and L34 ribosomal protein in the presence and absence of antibiotics enables susceptibility testing using MALDI-TOF mass spectrometry in 2h from Escherichia coli-positive blood cultures.
Hernández Egido S; Luis Reboredo A; García Señán A; Gil González AB; Muñoz Bellido JL; González Buitrago JM; Sánchez-Juanes F
Enferm Infecc Microbiol Clin (Engl Ed); 2019 Apr; 37(4):244-250. PubMed ID: 30236887
[TBL] [Abstract][Full Text] [Related]
11. A method for the detection of antibiotic resistance markers in clinical strains of Escherichia coli using MALDI mass spectrometry.
Hart PJ; Wey E; McHugh TD; Balakrishnan I; Belgacem O
J Microbiol Methods; 2015 Apr; 111():1-8. PubMed ID: 25633625
[TBL] [Abstract][Full Text] [Related]
12. A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry.
Schaumann R; Knoop N; Genzel GH; Losensky K; Rosenkranz C; Stîngu CS; Schellenberger W; Rodloff AC; Eschrich K
Med Sci Monit; 2012 Sep; 18(9):MT71-7. PubMed ID: 22936198
[TBL] [Abstract][Full Text] [Related]
13. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
14. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
Abrar S; Vajeeha A; Ul-Ain N; Riaz S
Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
[TBL] [Abstract][Full Text] [Related]
15. Rapid susceptibility testing of multi-drug resistant Escherichia coli and Klebsiella by glucose metabolization monitoring.
Kittel M; Findeisen P; Ghebremedhin B; Miethke T; Grundt A; Ahmad-Nejad P; Neumaier M
Clin Chem Lab Med; 2019 Jul; 57(8):1271-1279. PubMed ID: 30763260
[TBL] [Abstract][Full Text] [Related]
16. Detection of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae using the MALDI Biotyper Selective Testing of Antibiotic Resistance-β-Lactamase (MBT STAR-BL) assay.
Kawamoto Y; Kosai K; Yamakawa H; Kaku N; Uno N; Morinaga Y; Hasegawa H; Yanagihara K
J Microbiol Methods; 2019 May; 160():154-156. PubMed ID: 30904555
[TBL] [Abstract][Full Text] [Related]
17. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
19. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
20. Characterization of clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates, 2007-2009, China.
Zhang Y; Yang J; Ye L; Luo Y; Wang W; Zhou W; Cui Z; Han L
Microb Drug Resist; 2012 Oct; 18(5):465-70. PubMed ID: 22548669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
